CAVTHYSTA
Live / Registered — Registered (as of 05 May 2026)
What this means for you
Registered since 05 May 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 05 May 2032: the §8 declaration of use).
Record
- Serial number
- 97569457
- Registration number
- 8237952
- Mark type
- Word mark
- Filed
- 29 Aug 2022
- Published for opposition
- 17 Mar 2026
- Registered
- 05 May 2026
- Next maintenance filing
- §8 declaration of use, due by 05 May 2032 (grace period to 05 Nov 2032)
- Attorney of record
- Cara M. Kearney
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 05 May 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 May 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jan 2025 — REINSTATEMENT GRANTED - REQUEST TO DELETE 1(B) FILED
- 10 Jan 2025 — ASSIGNED TO PETITION STAFF
- 02 Dec 2024 — TEAS REQUEST FOR REINSTATEMENT
- 02 Dec 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Dec 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 08 Oct 2024 — TEAS DELETE 1(B) BASIS RECEIVED
- 30 Apr 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Mar 2024 — PUBLISHED FOR OPPOSITION
- 14 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED